LOCALLY ADVANCED (INOPERABLE) OR METASTATIC BREAST CANCER

Clinical trials for LOCALLY ADVANCED (INOPERABLE) OR METASTATIC BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED (INOPERABLE) OR METASTATIC BREAST CANCER trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED (INOPERABLE) OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New Triple-Threat treatment enters final testing for Tough-to-Treat breast cancer

Disease control Recruiting now

This study is testing whether adding a new drug called capivasertib to two standard breast cancer drugs works better for controlling advanced breast cancer. It will involve about 895 adults whose cancer is hormone receptor-positive, HER2-negative, and has worsened despite prior h…

Matched conditions: LOCALLY ADVANCED (INOPERABLE) OR METASTATIC BREAST CANCER

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Apr 01, 2026 23:11 UTC

LOCALLY ADVANCED (INOPERABLE) OR METASTATIC BREAST CANCER

Get alerted when new LOCALLY ADVANCED (INOPERABLE) OR METASTATIC BREAST CANCER trials appear

New Triple-Threat treatment enters final testing for Tough-to-Treat breast cancer